Our commitment to innovation
At Johnson & Johnson, we are committed to conducting our business with integrity and to continually earning the trust of the people we serve. These business practices help us to innovate responsibly, which in turn forms the foundation of our positive contribution to an equitable and inclusive society.
Investment in innovation is therefore critical to the sustainability of our business and long-term success. In addition to our vast internal scope of research and development (R&D) expertise, we invest in dedicated innovation centres, incubation for startups, strategic venture capital and business development.
Investment in innovation is therefore critical to the sustainability of our business and long-term success. In addition to our vast internal scope of research and development (R&D) expertise, we invest in dedicated innovation centres, incubation for startups, strategic venture capital and business development.
Research & development
Through the vast scope of R&D expertise across our business, we are innovating to transform healthcare. For example, at our Messovico site in Switzerland, operating surgeons can now provide individual patient scans that enable us to produce patient-specific skull, face and jaw implants in less than two days.
We apply data science and leverage digital healthcare across nearly our entire R&D portfolio – from discovery to development – to enhance and accelerate our innovation and drive impact for patients. We rely on the transformative power of scientific knowledge, data science, digital capabilities, emerging technologies and extensive collaboration to uncover innovative solutions across the full spectrum of healthcare.
We apply data science and leverage digital healthcare across nearly our entire R&D portfolio – from discovery to development – to enhance and accelerate our innovation and drive impact for patients. We rely on the transformative power of scientific knowledge, data science, digital capabilities, emerging technologies and extensive collaboration to uncover innovative solutions across the full spectrum of healthcare.
Our commitment to research & development
$15.1bn
$15.1bn invested in R&D in 20231
18%
This represents 18% of 2023 sales - an all time high for our company1
Innovation through collaboration
Across Johnson & Johnson, we advance product innovation through multiple external collaborations and partnerships across the world. Through our global innovation network, we connect life science and health technology innovators with the breadth and depth of offerings that are unique to Johnson & Johnson.
Working side by side with innovators throughout their journey, we offer a robust exchange of ideas and resources to help cultivate and shape their innovations and support their success. From identifying and facilitating potential collaborations to offering incubation and investment in promising healthcare solutions, we are committed to helping entrepreneurs who share our bold purpose to improve people’s lives around the world.
Working side by side with innovators throughout their journey, we offer a robust exchange of ideas and resources to help cultivate and shape their innovations and support their success. From identifying and facilitating potential collaborations to offering incubation and investment in promising healthcare solutions, we are committed to helping entrepreneurs who share our bold purpose to improve people’s lives around the world.
Our commitment to external collaboration in EMEA*
- $650M invested2**
- 175+ collaborations2
- 15 countries across Europe, Middle East and Africa2
**innovation centre data per Jforce as of Jan. 2, 2022
We believe a great idea can come from anywhere. Through our Johnson & Johnson Innovation organization, we aim to find and cultivate the world’s most promising, early stage healthcare innovation, wherever it originates.
Nerida Scott
Head of Johnson & Johnson Innovation,
EMEA
1Johnson & Johnson 2023 Annual Report: https://s203.q4cdn.com/636242992/files/doc_downloads/Annual_meeting/2024/Johnson-Johnson-2023-Annual-Report.pdf
2 Johnson & Johnson EMEA spotlight report: https://jnjinnovation.com/pages/emea-spotlight-2022
Featured stories
Following in our footprints: The importance of the healthcare industry demonstrating new standards of medical care, sustainably
Johnson & Johnson understands that the health of the planet is linked to the health of customers and people worldwide. The company aspires to raise awareness of the challenges of climate change and highlight the UK as a leader in encouraging large-scale sustainability initiatives across the country, to reduce the healthcare industry’s carbon footprint.
Developing a culturally sensitive mental healthcare model for communities in the UK affected by youth violence
By reducing barriers that have prevented underrepresented communities from accessing mental health services, Johnson & Johnson UK, in partnership with award-winning charity Power the Fight, aims to curb violence by empowering the young people and their families who have gone unsupported for far too long.